Biotech stocks are in a post-pandemic slump and recovery in 2024 is questionable
October 20, 2023 at 07:10 AM EDT
Once buoyed by demand for COVID-19 vaccines and treatments, the biotech industry is experiencing a sobering leveling out
Photography by Christophe Tomatis